Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435736 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders
10/14/2008US7435730 Short-acting benzodiazepines
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury
10/14/2008US7435586 Method of purification of cells
10/14/2008US7435547 Injectable or oral administration of a drug with an active ingredient of an extract from inflamed cutaneous tissue of rabbits inoculated with vaccinia virus; side effect reduction
10/14/2008CA2419279C Prodrugs to nmda receptor ligands
10/14/2008CA2387727C Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
10/14/2008CA2354576C Pharmaceutical preparation for inhalation of an opioid
10/14/2008CA2338649C New phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
10/14/2008CA2322380C Method of preventing the death of retinal neurons and treating ocular diseases
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2280310C Nmda antagonist
10/09/2008WO2008121860A1 Peripheral opioid receptor antagonists and uses thereof
10/09/2008WO2008121859A1 Methods of using tricyclic compounds in treating sodium channel-mediated diseases or conditions
10/09/2008WO2008121686A1 Sub-type selective azabicycloalkane derivatives
10/09/2008WO2008121064A1 New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705
10/09/2008WO2008121063A1 New imidazo[ 4,5-b]pyridine-7-carboxamides 704
10/09/2008WO2008120966A1 Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120778A1 Composition for promoting ketone compound formation
10/09/2008WO2008120766A1 Analgesic composition
10/09/2008WO2008120761A1 Heteroaryl derivative
10/09/2008WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same
10/09/2008WO2008120713A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions
10/09/2008WO2008120712A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008120562A1 Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia
10/09/2008WO2008119773A1 Amide derivatives as inhibitors of aspartyl proteases
10/09/2008WO2008119721A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119720A1 1-(1-cyclobutyl-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119719A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119718A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119717A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119716A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119715A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119714A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119713A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119712A1 Benzoimidazole derivatives which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119711A1 Substituted benzimidazolone compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119694A1 Benzimidazole cannabinoid agonists
10/09/2008WO2008119689A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/09/2008WO2008119618A1 Process of producing tomato paste
10/09/2008WO2008119238A1 Substituted five membered heterocycle compounds, preparation method and medical use thereof
10/09/2008WO2008119109A1 Treatment of neurological disorders
10/09/2008WO2008098978A3 Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
10/09/2008WO2008074679A3 4-imidazolines as taar's ligands
10/09/2008WO2008070795A3 Combination therapy using low-dose doxepin for the improvement of sleep
10/09/2008WO2008064342A3 Pde10 inhibitors and related compositions and methods
10/09/2008WO2008064337A3 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
10/09/2008WO2008058210A3 Local administration of gallium compositions to treat pain
10/09/2008WO2008015202A3 Anticonvulsive pharmaceutical compositions
10/09/2008WO2008002245A8 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
10/09/2008WO2008002244A8 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
10/09/2008WO2007100566A3 Use of dha and ara in the preparation of a composition for regulating gene expression
10/09/2008WO2007018660A3 Gabaergic imidazobenzodiazepine derivatives to treat memory deficits
10/09/2008US20080249319 Process for the preparation of 5-Carboxyphthalide
10/09/2008US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
10/09/2008US20080249184 Methods for modulating neuronal cell death
10/09/2008US20080249170 Magnesium compositions and uses thereof for neurological disorders
10/09/2008US20080249168 Pharmaceutical composition for gout
10/09/2008US20080249158 Pyrrole derivatives as therapeutic compounds
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
10/09/2008US20080249150 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
10/09/2008US20080249149 Serotonin receptor antagonists
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249142 N-methyl-5-(5-isopropoxy-3-pyridinyl)-4-penten-2-amine p-hydroxybenzoate; compounds can activate nicotinic receptor and can modulate neurotransmitter secretion; neuroprotective agents; side effects reduction; pains; easy to remove impurities; heck coupling reaction; CNS disorders; inflammatory disorders
10/09/2008US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease
10/09/2008US20080249138 Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases
10/09/2008US20080249135 Compounds for alzheimer's disease
10/09/2008US20080249132 Piperidine Carboxyamide Derivate Suitable as Tachykinin Receptor Antagonist
10/09/2008US20080249128 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
10/09/2008US20080249125 N-methyl-2-phenyl-2-{7-[2-(4-trifluoromethyl-phenyl)-ethyl]-4,7-dihydro-5H-thieno[2,3-c]pyridin-6-yl}-acetamide; sleep disorders
10/09/2008US20080249116 Aldehyde dehydrogenase; 3-(4-hydroxyphenyl)-7-[(5-phenyl(1,2,4-oxadiazol-3-yl))methoxy]-3-hydroquinazolin-4-one; alcoholism; cocaine and nicotine addictions
10/09/2008US20080249114 Beta-3 adrenergic receptor agonists; urinary tract infections, incontinence, gastrointestinal disorders, dysmenorrhea, obesity; tocolytic, anxiolytic, antidiabetic agents; antidepressants; 4-(2-hydroxy-3-(1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol
10/09/2008US20080249108 treatment of sleep disorders or inflammatory diseases of the bladder by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide methansulfonate
10/09/2008US20080249100 N-[2-(2-{[(3,4-dichlorophenyl)methyl]amino}-7-oxo-8-hydropteridin-8-yl)ethyl]carboxamides; antidiabetic, anticholesterol, anticarcinogenic, antiischemic, hypotensive agents; obesity, stroke
10/09/2008US20080249098 peripheral benzodiazepine receptors; 7-fluoro-N,N,5-trimethyl-4-oxo-3-(pyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide; for the treatment of various types of peripheral neuropathies, amyotrophic lateral sclerosis
10/09/2008US20080249094 Compounds for the treatment of neurodegenerative disorders
10/09/2008US20080249092 3-(phenylsulfonyl)-N-(tetrahydro-2H-pyran-4-ylmethyl)-8-quinolinamine; selectively modulating the cannabinoid 2 receptor; treatment of CNS disorders
10/09/2008US20080249083 isolated nucleic acids coding for novel glutaminyl-peptide cyclotransferase-like proteins (QPCTLs); isoenzymes; useful for the discovery of new therapeutic agents, for measuring cyclase activity; Alzheimer's disease, Familial British Dementia, Familial Danish Dementia, Down Syndrome, Huntington's disease
10/09/2008US20080249082 Use of Memantine (Namenda) to Treat Autism, Compulsivity and Impulsivity
10/09/2008US20080249081 Compounds for the treatment of pain and screening methods therefor
10/09/2008US20080249067 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP)
10/09/2008US20080249055 Use of Seh Inhibitors as Analgesics
10/09/2008US20080249041 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
10/09/2008US20080249030 Age Inhibitors
10/09/2008US20080249027 Heptapeptide having the sequence of CHEASQC; Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis
10/09/2008US20080249024 Peptides facilitating or inhibiting a nterograde transport
10/09/2008US20080249021 Biologically active peptides and their use for repairing injured nerves
10/09/2008US20080249017 Pharmaceutical formulations of ghrh molecules
10/09/2008US20080249008 Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor
10/09/2008US20080249006 Pharmaceutical Preparation for the Treatment of Shock
10/09/2008US20080249005 Use of Dm43 and Its Fragments as Matrix Metalloproteinases Inhibitor
10/09/2008US20080249004 Method of Modulating Cell Survival, Differentiation and/or Synaptic Plasticity
10/09/2008US20080248995 Contact candidate compound with transfected expression vector containing heterologous gene linked to PPAR promoter and expression vector encoding FOXO1 protein; compare level of expression with absence of candidate to identify promoter
10/09/2008US20080248994 Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
1 ... 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 ... 1833